Adverse Drug
Adverse drug reactions (ADRs) pose a significant threat to patient safety, driving research into accurate and efficient detection methods. Current research focuses on developing sophisticated machine learning models, including deep learning architectures like convolutional neural networks and transformers, often augmented with knowledge graphs and multimodal data (text and images) to improve ADR prediction and classification from diverse sources such as clinical trials, social media, and patient forums. These advancements aim to enhance pharmacovigilance, enabling earlier identification of potential risks and improved medication safety guidelines.
Papers
October 24, 2024
July 23, 2024
July 2, 2024
June 15, 2024
May 24, 2024
April 19, 2024
March 27, 2024
August 18, 2023
August 15, 2023
August 3, 2023
July 31, 2023
January 25, 2023
October 21, 2022
August 3, 2022
January 5, 2022